Nasdaq stocks posting largest volume decreases
AP - Fri Jan 09, 7:18PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
BDMS: 14.79 (-0.21), MBRG: 18.25 (unch), MGCD: 7.11 (-0.04), GCBC: 29.50 (unch), JAXB: 10.50 (unch)
MGC Diagnostics ups revenues 7% in Q4
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 5:40AM CST
MGCD: 7.11 (-0.04)
MGC Diagnostics' (MGCD) CEO Todd Austin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Jan 07, 10:19PM CST
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation EPS of -$0.07
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 3:09PM CST
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation Reports Fiscal 2014 Fourth Quarter and Full Year Results
PR Newswire - Wed Jan 07, 3:01PM CST
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the fourth quarter and fiscal year ended October 31, 2014.
MGCD: 7.11 (-0.04)
Industry veteran Terrence W. Bunge joins MGC Diagnostics Board
Business Wire - Thu Dec 18, 3:15PM CST
MGC Diagnostics (Nasdaq: MGCD) today announced that Terrence W. Bunge, an accomplished medical technology executive and investor, was elected to the company's Board of Directors, increasing the board's size to six members.
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Wednesday, January 7, 2015
PR Newswire - Thu Dec 11, 7:00AM CST
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2014, ended October 31, 2014. The call will be at 4:30 p.m. ET on Wednesday, January 7, 2015. The Company will report financial results for the fourth quarter and fiscal year 2014 after the markets close on Wednesday, January 7, 2015.
MGCD: 7.11 (-0.04)
Mgc Diagnostics (MGCD) Downgraded From Buy to Hold
at The Street - Fri Sep 12, 8:27AM CDT
Mgc Diagnostics (MGCD) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
MGCD: 7.11 (-0.04)
Nasdaq stocks posting largest percentage decreases
AP - Wed Sep 10, 5:16PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PXLW: 5.24 (-0.22), GTAT: 0.44 (+0.03), SGMA: 6.61 (-0.10), IMMR: 9.01 (-0.09), AMCC: 5.21 (+0.06), MGCD: 7.11 (-0.04), NPSP: 45.88 (+0.03), ISNS: 2.49 (+0.03), SHOS: 12.86 (+0.47), SAJA: 5.80 (-0.08)
MGC Diagnostics Corporation Reports 2014 Third Quarter Operating Results
PR Newswire - Tue Sep 09, 3:01PM CDT
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2014.
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation to Report Third Quarter Fiscal 2014 Financial Results on Tuesday, September 9, 2014
PR Newswire - Thu Aug 28, 7:00AM CDT
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the third quarter of fiscal 2014, ended July 31, 2014. The call will be at 4:30 p.m. ET on Tuesday, September 9, 2014. The Company will report financial results for the third quarter of fiscal 2014 after the markets close on Tuesday, September 9, 2014.
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation Completes Acquisition of MediSoft SA
PR Newswire - Fri Aug 01, 6:58AM CDT
MGC Diagnostics Corporation (NasdaqCM: MGCD), a leading global medical technologies company, announced today that it has completed its acquisition of MediSoft SA, a privately held manufacturer of cardiorespiratory diagnostic products based in Sorinnes, Belgium.
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation Completes Agreement to Acquire Medisoft SA
PR Newswire - Mon Jul 14, 4:00AM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a leading global medical technologies company, today announced that it has completed a stock purchase agreement to acquire Medisoft SA, a Sorinnes, Belgium headquartered, privately held manufacturer of market-leading cardiorespiratory diagnostic products. The Company plans to close the transaction on August 1, 2014.
MGCD: 7.11 (-0.04)
MGC Diagnostics Corporation Reports 2014 Second Quarter Operating Results
PR Newswire - Thu Jun 12, 3:01PM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarter ended April 30, 2014.
MGCD: 7.11 (-0.04)